Search research articles
Contact Us
Filters
Showing results (31-40 of 110) with videos related to
Page
of 11
Sort By:
Blood
|
May 14, 2010
Kidney disease associated with plasma cell dyscrasias
Eliot C Heher, Nelson B Goes, Thomas R Spitzer, et al.
American Journal of Hematology
|
September 9, 2014
Outcomes and management strategies for graft failure after umbilical cord blood transplantation
Harshabad Singh, Sarah Nikiforow, Shuli Li, et al.
Experimental Hematology
|
October 11, 2003
NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507
Christian Koenecke, Juanita Shaffer, Stephen I Alexander, et al.
Human Immunology
|
November 28, 2017
Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach
Hajime Sasaki, Tetsu Oura, Thomas R Spitzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2007
Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020
Thomas R Spitzer, Richard F Ambinder, Jeannette Y Lee, et al.
Bone Marrow Transplantation
|
October 26, 2019
Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases
Mark Leick, Bradley Hunter, Zachariah DeFilipp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 16, 2012
Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model
Raimon Duran-Struuck, Abraham Matar, Rebecca Crepeau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2003
Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants
Andrew Daly, Steven McAfee, Bimal Dey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2011
Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation
Yi-Bin Chen, Jessica P Driscoll, Steven L McAfee, et al.
Leukemia & Lymphoma
|
May 27, 2011
High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
Andrew A Lane, Steven L McAfee, Joanne Kennedy, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 110) with videos related to
Sort By:
Page
of 11
Blood
|
May 14, 2010
Kidney disease associated with plasma cell dyscrasias
Eliot C Heher, Nelson B Goes, Thomas R Spitzer, et al.
American Journal of Hematology
|
September 9, 2014
Outcomes and management strategies for graft failure after umbilical cord blood transplantation
Harshabad Singh, Sarah Nikiforow, Shuli Li, et al.
Experimental Hematology
|
October 11, 2003
NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507
Christian Koenecke, Juanita Shaffer, Stephen I Alexander, et al.
Human Immunology
|
November 28, 2017
Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach
Hajime Sasaki, Tetsu Oura, Thomas R Spitzer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2007
Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020
Thomas R Spitzer, Richard F Ambinder, Jeannette Y Lee, et al.
Bone Marrow Transplantation
|
October 26, 2019
Posttransplant cyclophosphamide in allogeneic bone marrow transplantation for the treatment of nonmalignant hematological diseases
Mark Leick, Bradley Hunter, Zachariah DeFilipp, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 16, 2012
Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model
Raimon Duran-Struuck, Abraham Matar, Rebecca Crepeau, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 19, 2003
Nonmyeloablative bone marrow transplantation: Infectious complications in 65 recipients of HLA-identical and mismatched transplants
Andrew Daly, Steven McAfee, Bimal Dey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 2, 2011
Treatment of parainfluenza 3 infection with DAS181 in a patient after allogeneic stem cell transplantation
Yi-Bin Chen, Jessica P Driscoll, Steven L McAfee, et al.
Leukemia & Lymphoma
|
May 27, 2011
High-dose chemotherapy with busulfan and cyclophosphamide and autologous stem cell rescue in patients with Hodgkin lymphoma
Andrew A Lane, Steven L McAfee, Joanne Kennedy, et al.
Page
of 11